| PRECLINICAL | evidence | Protein signatures for survival and recurrence in metastatic melanoma. | Thymosin beta 4 | — | 2011-06-10 |
| PRECLINICAL | evidence | Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model. | TB4 | — | 2011-06-01 |
| PRECLINICAL | evidence | Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model. | Thymosin beta 4 | — | 2011-06-01 |
| PRECLINICAL | evidence | Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. | Tbeta4 | Inflammation · preclinical | 2011-06-01 |
| PRECLINICAL | evidence | Thymosin-beta4 (Tbeta4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells. | Tbeta4 | Liver health | 2011-05-01 |
| PRECLINICAL | evidence | Measurements of spatiotemporal changes in G-actin concentration reveal its effect on stimulus-induced actin assembly and lamellipodium extension. | Thymosin beta 4 | preclinical | 2011-04-18 |
| PRECLINICAL | evidence | UPLC-ESI-MS analysis of thymosins beta4 and beta10 in cell lysates: a simple, rapid and sensitive quantification method. | Tbeta4 | — | 2011-03-01 |
| PRECLINICAL | evidence | [Biotechnological production of acetylated thymosin beta4]. | Thymosin beta 4 | Eye & vision health | 2011-03-01 |
| PRECLINICAL | evidence | Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. | Tbeta4 | Wound healing · preclinical | 2011-03-01 |
| PRECLINICAL | evidence | Thymosin beta4 expression in human tissues and in tumors using tissue microarrays. | Thymosin beta 4 | preclinical | 2011-03-01 |
| PRECLINICAL | evidence | beta-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up. | Thymosin beta 4 | — | 2011-02-11 |
| PRECLINICAL | evidence | Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. | Tbeta4 | — | 2011-02-01 |
| PRECLINICAL | evidence | Pretreatment with lipopolysaccharide modulates innate immunity in corneal fibroblasts challenged with Aspergillus fumigatus. | Tbeta4 | Immune function · preclinical | 2011-02-01 |
| PRECLINICAL | evidence | [The predictive value of dynamic changes of serum thymosin b4 in liver failure patients]. | Thymosin b4 | — | 2011-02-01 |
| PRECLINICAL | evidence | Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. | Thymosin β4 | — | 2011-01-01 |
| PRECLINICAL | evidence | In vitro and in vivo pro-angiogenic effects of thymosin-beta4-derived peptides. | Tbeta4 | Wound healing | 2011-01-01 |
| PRECLINICAL | evidence | Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. | Tbeta4 | Longevity & cellular aging | 2011-01-01 |
| PRECLINICAL | evidence | Significance of thymosin beta4 and implication of PINCH-1-ILK-alpha-parvin (PIP) complex in human dilated cardiomyopathy. | Tbeta4 | Inflammation | 2011-01-01 |
| PRECLINICAL | evidence | Expression pattern of thymosin beta 4 in the adult human liver. | Tbeta4 | — | 2011-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 expression correlates with lymph node metastasis through hypoxia inducible factor-alpha induction in breast cancer. | Tbeta4 | — | 2011-01-01 |
| PRECLINICAL | evidence | Muscle injury-induced thymosin beta4 acts as a chemoattractant for myoblasts. | Tbeta4 | Muscle growth & preservation | 2011-01-01 |
| PRECLINICAL | evidence | Relationship between serum thymosin beta4 levels and coronary collateral development. | Thymosin beta 4 | — | 2011-01-01 |
| PRECLINICAL | evidence | Lead-binding proteins: a review. | Thymosin β4 | — | 2011-01-01 |
| PRECLINICAL | evidence | Thymosins and muscle regeneration. | Tbeta4 | — | 2011-01-01 |
| PRECLINICAL | evidence | Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator. | TB4 | — | 2010-12-01 |
| PRECLINICAL | evidence | Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator. | Thymosin beta 4 | — | 2010-12-01 |
| PRECLINICAL | evidence | Whole blood, flow-chamber studies in real-time indicate a biphasic role for thymosin beta-4 in platelet adhesion. | Tbeta4 | Skin appearance & aging | 2010-12-01 |
| PRECLINICAL | evidence | Thymosin beta4 targeting impairs tumorigenic activity of colon cancer stem cells. | Tbeta4 | — | 2010-11-01 |
| PRECLINICAL | evidence | Thymosin beta4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner. | Thymosin beta 4 | — | 2010-11-01 |
| PRECLINICAL | evidence | Cooperation of actin-sequestering protein, thymosin beta-4 and hypoxia inducible factor-1alpha in tumor cell migration. | Tbeta4 | — | 2010-11-01 |
| PRECLINICAL | evidence | Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract. | Thymosin beta 4 | — | 2010-10-13 |
| PRECLINICAL | evidence | Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity. | Thymosin β4 | — | 2010-10-01 |
| PRECLINICAL | evidence | Cytoskeletal scaffolding proteins interact with Lynch-Syndrome associated mismatch repair protein MLH1. | Thymosin beta 4 | — | 2010-09-01 |
| PRECLINICAL | evidence | Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1alpha stabilization in HeLa human cervical tumor cells. | Thymosin beta 4 | — | 2010-08-28 |
| PRECLINICAL | evidence | Biological activities of thymosin beta4 defined by active sites in short peptide sequences. | Thymosin beta 4 | — | 2010-07-01 |
| PRECLINICAL | evidence | Quantification of thymosin beta(4) in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | Thymosin beta 4 | — | 2010-07-01 |
| PRECLINICAL | evidence | Quantification of thymosin beta(4) in human cerebrospinal fluid using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | TB4 | — | 2010-07-01 |
| PRECLINICAL | evidence | Protection of thymosin beta-4 on corneal endothelial cells from UVB-induced apoptosis. | Tbeta4 | Longevity & cellular aging · preclinical | 2010-06-30 |
| PRECLINICAL | evidence | Reversal of second-hand cigarette smoke-induced impairment of corneal wound healing by thymosin beta4 combined with anti-inflammatory agents. | Tbeta4 | — | 2010-05-01 |
| PRECLINICAL | evidence | Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4. | Thymosin beta 4 | Glycemic control | 2010-05-01 |
| PRECLINICAL | evidence | Thymosin beta4 and cardiac repair. | Tbeta4 | Wound healing | 2010-04-01 |
| PRECLINICAL | evidence | Thymosin beta4: a candidate for treatment of stroke? | Tbeta4 | Neuroprotection | 2010-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 and its posttranslational modifications. | Thymosin beta 4 | — | 2010-04-01 |
| PRECLINICAL | evidence | Repolymerization of actin from actin:thymosin beta4 complex induced by diaphanous related formins and gelsolin. | Tbeta4 | — | 2010-04-01 |
| PRECLINICAL | evidence | Multifunctionality of the beta-thymosin/WH2 module: G-actin sequestration, actin filament growth, nucleation, and severing. | Thymosin beta 4 | — | 2010-04-01 |
| PRECLINICAL | evidence | Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases. | Thymosin beta 4 | — | 2010-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80. | Tbeta4 | — | 2010-04-01 |
| PRECLINICAL | evidence | Progression of ocular sulfur mustard injury: development of a model system. | Tbeta4 | Wound healing | 2010-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. | Tbeta4 | Wound healing | 2010-04-01 |
| PRECLINICAL | evidence | Thymosin beta4 in multiple myeloma: friend or foe. | Tbeta4 | — | 2010-04-01 |